1. Home
  2. DMAC
  3. DMAC News

Latest DiaMedica Therapeutics Inc. (DMAC) News on October 28, 2025

Wall Street Analysts Believe DiaMedica Therapeutics (DMAC) Could Rally 100.81%: Here's is How to Trade
DMAC

Zacks

2 months ago

Wall Street Analysts Believe DiaMedica Therapeutics (DMAC) Could Rally 100.81%: Here's is How to Trade

DiaMedica Therapeutics Insiders Placed Bullish Bets Worth US$43.1m
DMAC

Simply Wall St.

2 months ago

DiaMedica Therapeutics Insiders Placed Bullish Bets Worth US$43.1m

DiaMedica Therapeutics to Participate in Upcoming Investor Conferences
DMAC

Business Wire

2 months ago

DiaMedica Therapeutics to Participate in Upcoming Investor Conferences

DiaMedica Therapeutics to Participate in Cantor Global Healthcare Conference
DMAC

Business Wire

2 months ago

DiaMedica Therapeutics to Participate in Cantor Global Healthcare Conference

DMAC

MT Newswires

3 months ago

DiaMedica Therapeutics Unveils Positive Interim Results in Phase 2 of Preeclampsia Study

DiaMedica Therapeutics Reports Positive Interim Phase 2 Preeclampsia Results: Statistically Significant Reductions in Blood Pressure and No Placental Transfer
DMAC

Business Wire

3 months ago

DiaMedica Therapeutics Reports Positive Interim Phase 2 Preeclampsia Results: Statistically Significant Reductions in Blood Pressure and No Placental Transfer

3 Promising Penny Stocks With Market Caps Under $200M
DMAC

Simply Wall St.

3 months ago

3 Promising Penny Stocks With Market Caps Under $200M

DiaMedica Therapeutics Announces Inclusion in the Russell 2000® and Russell 3000® Indexes
DMAC

Business Wire

4 months ago

DiaMedica Therapeutics Announces Inclusion in the Russell 2000® and Russell 3000® Indexes

With 39% ownership, DiaMedica Therapeutics Inc. (NASDAQ:DMAC) insiders have a lot riding on the company's future
DMAC

Simply Wall St.

5 months ago

With 39% ownership, DiaMedica Therapeutics Inc. (NASDAQ:DMAC) insiders have a lot riding on the company's future

DiaMedica Therapeutics to Present at Jefferies Global Healthcare Conference 2025
DMAC

Business Wire

5 months ago

DiaMedica Therapeutics to Present at Jefferies Global Healthcare Conference 2025

DiaMedica Therapeutics Announces Key Opinion Leader Webinar on DM199 (Rinvecalinase Alfa) for the Treatment of Preeclampsia
DMAC

Business Wire

5 months ago

DiaMedica Therapeutics Announces Key Opinion Leader Webinar on DM199 (Rinvecalinase Alfa) for the Treatment of Preeclampsia

DiaMedica Therapeutics Inc (DMAC) Q1 2025 Earnings Call Highlights: Strong Financial Position ...
DMAC

GuruFocus.com

5 months ago

DiaMedica Therapeutics Inc (DMAC) Q1 2025 Earnings Call Highlights: Strong Financial Position ...

DMAC

Thomson Reuters StreetEvents

5 months ago

Q1 2025 DiaMedica Therapeutics Inc Earnings Call

DiaMedica Therapeutics Announces Poster Presentation at European Stroke Organisation Conference – ESOC 2025
DMAC

Business Wire

5 months ago

DiaMedica Therapeutics Announces Poster Presentation at European Stroke Organisation Conference – ESOC 2025

DiaMedica Therapeutics Reports First Quarter 2025 Financial Results And Provides Business Highlights
DMAC

Business Wire

5 months ago

DiaMedica Therapeutics Reports First Quarter 2025 Financial Results And Provides Business Highlights

DiaMedica Therapeutics to Participate in Upcoming Investor Conferences in May
DMAC

Business Wire

6 months ago

DiaMedica Therapeutics to Participate in Upcoming Investor Conferences in May

DiaMedica Therapeutics to Report First Quarter 2025 Financial Results and Provide a Business Update May 14, 2025
DMAC

Business Wire

6 months ago

DiaMedica Therapeutics to Report First Quarter 2025 Financial Results and Provide a Business Update May 14, 2025

We're Hopeful That DiaMedica Therapeutics (NASDAQ:DMAC) Will Use Its Cash Wisely
DMAC

Simply Wall St.

6 months ago

We're Hopeful That DiaMedica Therapeutics (NASDAQ:DMAC) Will Use Its Cash Wisely

DiaMedica Therapeutics Inc (DMAC) Q4 2024 Earnings Call Highlights: Strong Financial Position ...
DMAC

GuruFocus.com

7 months ago

DiaMedica Therapeutics Inc (DMAC) Q4 2024 Earnings Call Highlights: Strong Financial Position ...

DMAC

Thomson Reuters StreetEvents

7 months ago

Q4 2024 DiaMedica Therapeutics Inc Earnings Call

DiaMedica Therapeutics Provides a Business Update and Announces Full Year 2024 Financial Results
DMAC

Business Wire

7 months ago

DiaMedica Therapeutics Provides a Business Update and Announces Full Year 2024 Financial Results

Insider Stock Buying Reaches US$9.00m On DiaMedica Therapeutics
DMAC

Simply Wall St.

7 months ago

Insider Stock Buying Reaches US$9.00m On DiaMedica Therapeutics

DiaMedica Therapeutics to Report Fourth Quarter 2024 Financial Results and Provide a Business Update March 18, 2025
DMAC

Business Wire

8 months ago

DiaMedica Therapeutics to Report Fourth Quarter 2024 Financial Results and Provide a Business Update March 18, 2025

DiaMedica Therapeutics Appoints Daniel J. O’Connor to the Board of Directors
DMAC

Business Wire

8 months ago

DiaMedica Therapeutics Appoints Daniel J. O’Connor to the Board of Directors

DiaMedica Therapeutics Announces Publication of DM199’s Mechanism of Action for the Treatment of Acute Ischemic Stroke (AIS) in the Journal Stroke
DMAC

Business Wire

8 months ago

DiaMedica Therapeutics Announces Publication of DM199’s Mechanism of Action for the Treatment of Acute Ischemic Stroke (AIS) in the Journal Stroke

DiaMedica Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
DMAC

Business Wire

9 months ago

DiaMedica Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Individual investors are DiaMedica Therapeutics Inc.'s (NASDAQ:DMAC) biggest owners and were hit after market cap dropped US$26m
DMAC

Simply Wall St.

10 months ago

Individual investors are DiaMedica Therapeutics Inc.'s (NASDAQ:DMAC) biggest owners and were hit after market cap dropped US$26m

DiaMedica Therapeutics Announces Formation of Scientific Advisor Board to Support the Development of DM199 for the Treatment of Preeclampsia
DMAC

Business Wire

a year ago

DiaMedica Therapeutics Announces Formation of Scientific Advisor Board to Support the Development of DM199 for the Treatment of Preeclampsia

We're Not Very Worried About DiaMedica Therapeutics' (NASDAQ:DMAC) Cash Burn Rate
DMAC

Simply Wall St.

a year ago

We're Not Very Worried About DiaMedica Therapeutics' (NASDAQ:DMAC) Cash Burn Rate

DMAC

Thomson Reuters StreetEvents

a year ago

Q3 2024 DiaMedica Therapeutics Inc Earnings Call

DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2024 Financial Results
DMAC

Business Wire

a year ago

DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2024 Financial Results

DiaMedica Therapeutics Announces Dosing of First Patient in Phase 2 Trial of DM199 in the Treatment of Preeclampsia
DMAC

Business Wire

a year ago

DiaMedica Therapeutics Announces Dosing of First Patient in Phase 2 Trial of DM199 in the Treatment of Preeclampsia

DiaMedica Therapeutics to Participate in Upcoming Craig-Hallum 15th Annual Alpha Select Conference
DMAC

Business Wire

a year ago

DiaMedica Therapeutics to Participate in Upcoming Craig-Hallum 15th Annual Alpha Select Conference

DiaMedica Therapeutics to Provide a Business Update and Report Third Quarter 2024 Financial Results November 14, 2024
DMAC

Business Wire

a year ago

DiaMedica Therapeutics to Provide a Business Update and Report Third Quarter 2024 Financial Results November 14, 2024

Best Momentum Stocks to Buy for October 14th
DMAC

Zacks

a year ago

Best Momentum Stocks to Buy for October 14th

DiaMedica gets SAHPRA approval for Phase II preeclampsia treatment trial
DMAC

Clinical Trials Arena

a year ago

DiaMedica gets SAHPRA approval for Phase II preeclampsia treatment trial

DMAC

MT Newswires

a year ago

DiaMedica Says It Receives South Africa Approval to Start Mid-Stage Trial for Preeclampsia Treatment

DiaMedica Therapeutics Announces Regulatory Approval to Begin Phase 2 Trial of DM199 in the Treatment of Preeclampsia
DMAC

Business Wire

a year ago

DiaMedica Therapeutics Announces Regulatory Approval to Begin Phase 2 Trial of DM199 in the Treatment of Preeclampsia

DiaMedica Therapeutics Insiders Placed Bullish Bets Worth US$9.05m
DMAC

Simply Wall St.

a year ago

DiaMedica Therapeutics Insiders Placed Bullish Bets Worth US$9.05m

DiaMedica Therapeutics Upcoming Conference Participation
DMAC

Business Wire

a year ago

DiaMedica Therapeutics Upcoming Conference Participation

Is Atossa Genetics (ATOS) Outperforming Other Medical Stocks This Year?
DMAC

Zacks

a year ago

Is Atossa Genetics (ATOS) Outperforming Other Medical Stocks This Year?

DiaMedica Therapeutics Provides a Business Update and Announces Second Quarter 2024 Financial Results
DMAC

Business Wire

a year ago

DiaMedica Therapeutics Provides a Business Update and Announces Second Quarter 2024 Financial Results

Are Medical Stocks Lagging DiaMedica Therapeutics (DMAC) This Year?
DMAC

Zacks

a year ago

Are Medical Stocks Lagging DiaMedica Therapeutics (DMAC) This Year?

DiaMedica Therapeutics to Provide a Business Update and Report Second Quarter 2024 Financial Results August 8, 2024
DMAC

Business Wire

a year ago

DiaMedica Therapeutics to Provide a Business Update and Report Second Quarter 2024 Financial Results August 8, 2024

DiaMedica Therapeutics Inc.'s (NASDAQ:DMAC) largest shareholders are individual investors with 50% ownership, insiders own 39%
DMAC

Simply Wall St.

a year ago

DiaMedica Therapeutics Inc.'s (NASDAQ:DMAC) largest shareholders are individual investors with 50% ownership, insiders own 39%

DiaMedica Therapeutics Releases Preeclampsia White Paper and Announces Key Opinion Leader Webinar on DM199 (Rinvecalinase Alfa) for the Treatment of Preeclampsia
DMAC

Business Wire

a year ago

DiaMedica Therapeutics Releases Preeclampsia White Paper and Announces Key Opinion Leader Webinar on DM199 (Rinvecalinase Alfa) for the Treatment of Preeclampsia

DiaMedica Therapeutics Announces Closing of $11.8 Million Private Placement
DMAC

Business Wire

a year ago

DiaMedica Therapeutics Announces Closing of $11.8 Million Private Placement

DiaMedica Therapeutics Announces $11.8 Million Private Placement
DMAC

Business Wire

a year ago

DiaMedica Therapeutics Announces $11.8 Million Private Placement

DiaMedica Therapeutics Announces Expansion of DM199 (Rinvecalinase Alfa) Program Into Preeclampsia
DMAC

Business Wire

a year ago

DiaMedica Therapeutics Announces Expansion of DM199 (Rinvecalinase Alfa) Program Into Preeclampsia

We're Not Very Worried About DiaMedica Therapeutics' (NASDAQ:DMAC) Cash Burn Rate
DMAC

Simply Wall St.

a year ago

We're Not Very Worried About DiaMedica Therapeutics' (NASDAQ:DMAC) Cash Burn Rate

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q1 2024 Earnings Call Transcript
DMAC

Insider Monkey

a year ago

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q1 2024 Earnings Call Transcript

DiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2024 Financial Results
DMAC

Business Wire

a year ago

DiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2024 Financial Results

DMAC

Business Wire

a year ago

DiaMedica Therapeutics to Report First Quarter 2024 Financial Results and Provide a Business Update May 9, 2024

Bullish DiaMedica Therapeutics Insiders Loaded Up On US$15.7m Of Stock
DMAC

Simply Wall St.

a year ago

Bullish DiaMedica Therapeutics Insiders Loaded Up On US$15.7m Of Stock

DiaMedica (DMAC) Up as Stroke Study Dosing Begins Post Relaunch
DMAC

Zacks

2 years ago

DiaMedica (DMAC) Up as Stroke Study Dosing Begins Post Relaunch

DiaMedica Therapeutics Announces First Patient Dosed in Relaunch of its Pivotal Phase 2/3 ReMEDy2 Trial of DM199 for the Treatment of Acute Ischemic Stroke
DMAC

Business Wire

2 years ago

DiaMedica Therapeutics Announces First Patient Dosed in Relaunch of its Pivotal Phase 2/3 ReMEDy2 Trial of DM199 for the Treatment of Acute Ischemic Stroke

DiaMedica Therapeutics (DMAC) Loses -19.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
DMAC

Zacks

2 years ago

DiaMedica Therapeutics (DMAC) Loses -19.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q4 2023 Earnings Call Transcript
DMAC

Insider Monkey

2 years ago

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q4 2023 Earnings Call Transcript

DiaMedica Therapeutics Inc.'s (NASDAQ:DMAC) Path To Profitability
DMAC

Simply Wall St.

2 years ago

DiaMedica Therapeutics Inc.'s (NASDAQ:DMAC) Path To Profitability

DiaMedica Therapeutics Provides a Business Update and Announces Full Year 2023 Financial Results
DMAC

Business Wire

2 years ago

DiaMedica Therapeutics Provides a Business Update and Announces Full Year 2023 Financial Results

DiaMedica Therapeutics Announces Poster Presentation at International Stroke Conference
DMAC

Business Wire

2 years ago

DiaMedica Therapeutics Announces Poster Presentation at International Stroke Conference

FingerMotion Provides Supplemental Quarterly Guidance
DMAC

ACCESSWIRE

2 years ago

FingerMotion Provides Supplemental Quarterly Guidance

Recent Price Trend in Pangaea Logistics (PANL) is Your Friend, Here's Why
DMAC

Zacks

2 years ago

Recent Price Trend in Pangaea Logistics (PANL) is Your Friend, Here's Why

DiaMedica Therapeutics Appoints Dr. Lorianne Masuoka as Chief Medical Officer
DMAC

Business Wire

2 years ago

DiaMedica Therapeutics Appoints Dr. Lorianne Masuoka as Chief Medical Officer

Perspective Therapeutics Announces Pricing of $60.0 Million Public Offering And $20.8 Million Private Placement
DMAC

GlobeNewswire

2 years ago

Perspective Therapeutics Announces Pricing of $60.0 Million Public Offering And $20.8 Million Private Placement

Sales And Marketing Software Stocks Q3 Highlights: Sprinklr (NYSE:CXM)
DMAC

StockStory

2 years ago

Sales And Marketing Software Stocks Q3 Highlights: Sprinklr (NYSE:CXM)

Office Properties Income Trust Reduces Quarterly Dividend to Increase Liquidity and Financial Flexibility Going Forward
DMAC

Business Wire

2 years ago

Office Properties Income Trust Reduces Quarterly Dividend to Increase Liquidity and Financial Flexibility Going Forward

Automotive Chipmakers Squeezed By 'Accordion Effect'
DMAC

Investor's Business Daily

2 years ago

Automotive Chipmakers Squeezed By 'Accordion Effect'

SKYX Will Debut Its New Patented Game-Changing Smart Home Platforms Technologies at CES 2024 - Opening Today, January 9th in Las Vegas
DMAC

ACCESSWIRE

2 years ago

SKYX Will Debut Its New Patented Game-Changing Smart Home Platforms Technologies at CES 2024 - Opening Today, January 9th in Las Vegas

DiaMedica Therapeutics Inc.'s (NASDAQ:DMAC) largest shareholders are individual investors with 52% ownership, insiders own 37%
DMAC

Simply Wall St.

2 years ago

DiaMedica Therapeutics Inc.'s (NASDAQ:DMAC) largest shareholders are individual investors with 52% ownership, insiders own 37%

Unity Bancorp (UNTY) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
DMAC

Zacks

2 years ago

Unity Bancorp (UNTY) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

Porch Group Announces New Partnerships and Growth in its Utilities Channel
DMAC

Business Wire

2 years ago

Porch Group Announces New Partnerships and Growth in its Utilities Channel

Clarus Enters into Definitive Agreement to Sell Precision Sport Segment
DMAC

GlobeNewswire

2 years ago

Clarus Enters into Definitive Agreement to Sell Precision Sport Segment

Here's Why We're Not Too Worried About DiaMedica Therapeutics' (NASDAQ:DMAC) Cash Burn Situation
DMAC

Simply Wall St.

2 years ago

Here's Why We're Not Too Worried About DiaMedica Therapeutics' (NASDAQ:DMAC) Cash Burn Situation

Hamilton Beach Brands Holding (NYSE:HBB) investors are sitting on a loss of 18% if they invested five years ago
DMAC

Simply Wall St.

2 years ago

Hamilton Beach Brands Holding (NYSE:HBB) investors are sitting on a loss of 18% if they invested five years ago

Billionaire Lee Cooperman’s 10 Stock Picks with Huge Upside Potential
DMAC

Insider Monkey

2 years ago

Billionaire Lee Cooperman’s 10 Stock Picks with Huge Upside Potential

DMAC

PR Newswire

2 years ago

KLX Energy Services to Present at Sidoti Small Cap Conference on December 6th

Pioneer Closed End Funds Required Notice to Shareholders Sources of Distribution Under Section 19(a)
DMAC

Business Wire

2 years ago

Pioneer Closed End Funds Required Notice to Shareholders Sources of Distribution Under Section 19(a)

ATRenew to use Chinese experience to support electronics recycling partners worldwide
DMAC

News Direct

2 years ago

ATRenew to use Chinese experience to support electronics recycling partners worldwide

KLX Energy Services Holdings, Inc. (NASDAQ:KLXE) most popular amongst individual investors who own 40% of the shares, institutions hold 30%
DMAC

Simply Wall St.

2 years ago

KLX Energy Services Holdings, Inc. (NASDAQ:KLXE) most popular amongst individual investors who own 40% of the shares, institutions hold 30%

DMAC

Reuters

2 years ago

UPDATE 1-DouYu International forms committee to manage ops after CEO's arrest

Implied Volatility Surging for Agora (API) Stock Options
DMAC

Zacks

2 years ago

Implied Volatility Surging for Agora (API) Stock Options

Stoke Therapeutics to Present Data from the Company’s Dravet Syndrome Clinical Program at the American Epilepsy Society 2023 Annual Meeting
DMAC

Business Wire

2 years ago

Stoke Therapeutics to Present Data from the Company’s Dravet Syndrome Clinical Program at the American Epilepsy Society 2023 Annual Meeting

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q3 2023 Earnings Call Transcript
DMAC

Insider Monkey

2 years ago

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q3 2023 Earnings Call Transcript

DMAC

Thomson Reuters StreetEvents

2 years ago

Q3 2023 DiaMedica Therapeutics Inc Earnings Call

DiaMedica Therapeutics Inc. (DMAC) Reports Third Quarter 2023 Financial Results
DMAC

GuruFocus.com

2 years ago

DiaMedica Therapeutics Inc. (DMAC) Reports Third Quarter 2023 Financial Results

Insider Sell Alert: Director MOORE DAN T III Sells Shares of Park-Ohio Holdings Corp (PKOH)
DMAC

GuruFocus.com

2 years ago

Insider Sell Alert: Director MOORE DAN T III Sells Shares of Park-Ohio Holdings Corp (PKOH)

Time To Worry? Analysts Are Downgrading Their Brilliant Earth Group, Inc. (NASDAQ:BRLT) Outlook
DMAC

Simply Wall St.

2 years ago

Time To Worry? Analysts Are Downgrading Their Brilliant Earth Group, Inc. (NASDAQ:BRLT) Outlook

Maravai LifeSciences Announces November 2023 Investor Conference Schedule
DMAC

GlobeNewswire

2 years ago

Maravai LifeSciences Announces November 2023 Investor Conference Schedule

CORRECTING AND REPLACING: NOVONIX Finalizes US$100 Million Grant Award from U.S. Department of Energy
DMAC

GlobeNewswire

2 years ago

CORRECTING AND REPLACING: NOVONIX Finalizes US$100 Million Grant Award from U.S. Department of Energy

Oculis to Present a Late-Breaking Abstract at the American Academy of Ophthalmology 2023 Annual Meeting on the Positive Stage 1 Results from Phase 3 DIAMOND Trial for Diabetic Macular Edema
DMAC

GlobeNewswire

2 years ago

Oculis to Present a Late-Breaking Abstract at the American Academy of Ophthalmology 2023 Annual Meeting on the Positive Stage 1 Results from Phase 3 DIAMOND Trial for Diabetic Macular Edema

Solid Power, Inc. Announces Timing of Third Quarter 2023 Earnings Release Date and Conference Call
DMAC

GlobeNewswire

2 years ago

Solid Power, Inc. Announces Timing of Third Quarter 2023 Earnings Release Date and Conference Call

Share on Social Networks: